Laserfiche WebLink
F <br /> fitly 27, 1990 <br /> Site Safety Plan <br /> ARCO Station No.6100, Tracy, Califamia <br /> • The elapsed time since the, removal of the cartridges or filters from their <br /> protective packaging <br /> • The emotional state of the wearer <br /> • The level of physical activity of the wearer <br /> Cartridges designed and specified to protect the wearer against airborne particles are not <br /> appropriate for protection against gases and vapors. Cartridges designed and specified for <br /> r protection against specific gases and vapors are not appropriate for protection against <br /> airborne particles or other gases or vapors beyond the scope of that type of cartridge. Every <br /> cartridge. Every cartridge is labeled with specific instructions defining the use and + <br /> limitations of that particular type of cartridge. rf the level is missing or tl;e type of cartridge 1 <br /> under any circumstances;it will provide little or no <br /> is inappropriate than it may not be used <br /> protection to the wearer. <br /> Danger Signals Indicating Possible Respirator Failare <br /> If any of the danger signals in the following list are experienced while wearing a respirator, <br /> immediately return to a fresh air environment. The cartridges or filters may be , <br /> �• inappropriate or used up or abnormal conditions may be creating vapor concentrations, } <br /> .. <br /> which are beyond the limits of the cartridges or filters. Danger is indicated when the <br /> individual subject to exposure: <br /> Smells or tastes chemicals, or if eyes, nose, or throat become irritated; <br /> Has difficulty breathing, <br /> Notices that the breathing air becomes uncomfortably warm; <br /> • Experiences headaches, dizziness, cramps, nausea, or blurred vision; <br /> • Experiences changes in complexion or skin discoloration; <br /> . Experiences changes in motor coordination, personality, or demeanor; <br /> Experiences changes in speech ability or pattern; <br /> Experiences excessive salivation or changes in pupillary response. <br /> Doc#AR06767W.I.1 <br />